{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:45:05Z","timestamp":1790095505521,"version":"4.0.1"},"reference-count":40,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Novo Nordisk A\/S"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To compare the risk of fetal overgrowth and preterm delivery in pregnant women with type 1 diabetes (T1D) treated with insulin pumps versus multiple daily injections (MDI) and examine whether possible differences were mediated through improved glycemic control or gestational weight gain during pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>The risk of pregnancy and perinatal outcomes were evaluated in a cohort of 2,003 pregnant women with T1D enrolled from 17 countries in a real-world setting during 2013\u20132018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In total, 723 women were treated with pumps and 1,280 with MDI. At inclusion (median gestational weeks 8.6 [interquartile range 7\u201310]), pump users had lower mean HbA1c (mean \u00b1 SD 50.6 \u00b1 9.8 mmol\/mol [6.8 \u00b1 0.9%] vs. 53.6 \u00b1 13.8 mmol\/mol [7.1 \u00b1 1.3%], P &amp;lt; 0.001), longer diabetes duration (18.4 \u00b1 7.8 vs. 14.4 \u00b1 8.2 years, P &amp;lt; 0.001), and higher prevalence of retinopathy (35.3% vs. 24.4%, P &amp;lt; 0.001). Proportions of large for gestational age (LGA) offspring and preterm delivery were 59.0% vs. 52.2% (adjusted odds ratio [OR] 1.36 [95% CI 1.09; 1.70], P = 0.007) and 39.6% vs. 32.1% (adjusted OR 1.46 (95% CI 1.17; 1.82), P &amp;lt; 0.001), respectively. The results did not change after adjustment for HbA1c or gestational weight gain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Insulin pump treatment in pregnant women with T1D, prior to the widespread use of continuous glucose monitoring or automated insulin delivery, was associated with a higher risk of LGA offspring and preterm delivery compared with MDI in crude and adjusted analyses. This association did not appear to be mediated by differences in glycemic control as represented by HbA1c or by gestational weight gain.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc23-1281","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T21:45:53Z","timestamp":1703195153000},"page":"384-392","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":9,"title":["Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort"],"prefix":"10.2337","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-457X","authenticated-orcid":false,"given":"Ida Holte","family":"Thorius","sequence":"first","affiliation":[{"name":"1Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark"},{"name":"2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"3Novo Nordisk A\/S, S\u00f8borg, Denmark"},{"name":"4Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Frederiksberg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Lotte N.","family":"Husemoen","sequence":"additional","affiliation":[{"name":"3Novo Nordisk A\/S, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Baastrup","family":"Nordsborg","sequence":"additional","affiliation":[{"name":"3Novo Nordisk A\/S, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amra C.","family":"Alibegovic","sequence":"additional","affiliation":[{"name":"3Novo Nordisk A\/S, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari-Anne","family":"Gall","sequence":"additional","affiliation":[{"name":"3Novo Nordisk A\/S, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Petersen","sequence":"additional","affiliation":[{"name":"4Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, Copenhagen University Hospital, Frederiksberg, Denmark"},{"name":"5Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damm","sequence":"additional","affiliation":[{"name":"2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"6Department of Obstetrics, Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3279-0863","authenticated-orcid":false,"given":"Elisabeth R.","family":"Mathiesen","sequence":"additional","affiliation":[{"name":"1Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen, Denmark"},{"name":"2Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"2024022320511181800_B1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/dc09-0656","article-title":"Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study","volume":"32","author":"Persson","year":"2009","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jdiacomp.2007.03.008","article-title":"Elevated third-trimester haemoglobin A 1c predicts preterm delivery in type 1 diabetes","volume":"22","author":"Ekbom","year":"2008","journal-title":"J Diabetes Complications"},{"key":"2024022320511181800_B3","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc18-1437","article-title":"Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial","volume":"41","author":"Feig","year":"2018","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41574-019-0197-3","article-title":"Improving pregnancy outcomes in women with diabetes mellitus: modern management","volume":"15","author":"Ringholm","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2024022320511181800_B5","doi-asserted-by":"crossref","first-page":"e008870","DOI":"10.1161\/JAHA.118.008870","article-title":"Birth weight and risk of type 2 diabetes mellitus, cardiovascular disease, and hypertension in adults: a meta-analysis of 7\u00a0646\u00a0267 participants from 135 studies","volume":"7","author":"Knop","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024022320511181800_B6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00125-018-4758-0","article-title":"Association between maternal diabetes, being large for gestational age and breast-feeding on being overweight or obese in childhood","volume":"62","author":"Kaul","year":"2019","journal-title":"Diabetologia"},{"key":"2024022320511181800_B7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1542\/peds.2006-3260","article-title":"Preterm infants as young adults: a Swedish national cohort study","volume":"120","author":"Lindstr\u00f6m","year":"2007","journal-title":"Pediatrics"},{"key":"2024022320511181800_B8","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00125-021-05482-8","article-title":"Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes","volume":"64","author":"S\u00f8holm","year":"2021","journal-title":"Diabetologia"},{"key":"2024022320511181800_B9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"key":"2024022320511181800_B10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/dc14-1755","article-title":"Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes","volume":"38","author":"Maresh","year":"2015","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/dme.13861","article-title":"Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection","volume":"36","author":"Hauffe","year":"2019","journal-title":"Diabet Med"},{"key":"2024022320511181800_B12","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3109\/14767058.2013.794214","article-title":"Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning foetal and neonatal complications?","volume":"26","author":"Colstrup","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2024022320511181800_B13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00125-013-3108-5","article-title":"Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study","volume":"57","author":"Tennant","year":"2014","journal-title":"Diabetologia"},{"key":"2024022320511181800_B14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2008-1415","article-title":"Clinical review: hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections","volume":"94","author":"Fatourechi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024022320511181800_B15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/dia.2016.0412","article-title":"Pregnancy outcomes and insulin requirements in women with type 1 diabetes treated with continuous subcutaneous insulin infusion and multiple daily injections: cohort study","volume":"19","author":"Abell","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"2024022320511181800_B16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/14767058.2013.837444","article-title":"Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes","volume":"27","author":"Mathiesen","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2024022320511181800_B17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/dia.2009.0081","article-title":"Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning","volume":"12","author":"Cyganek","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"2024022320511181800_B18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/dia.2009.0140","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes","volume":"12","author":"Gonz\u00e1lez-Romero","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"2024022320511181800_B19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/dia.2015.0165","article-title":"Continuous subcutaneous insulin infusion during pregnancy in women with complicated type 1 diabetes is associated with better glycemic control but not with improvement in pregnancy outcomes","volume":"18","author":"Kek\u00e4l\u00e4inen","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"2024022320511181800_B20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/dia.2010.0111","article-title":"Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin","volume":"12","author":"Chico","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"2024022320511181800_B21","doi-asserted-by":"crossref","first-page":"109854","DOI":"10.1016\/j.diabres.2022.109854","article-title":"Associations of insulin pump and continuous glucose monitoring use with pregnancy-related outcomes in women with type 1 diabetes","volume":"187","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2024022320511181800_B22","doi-asserted-by":"crossref","first-page":"108628","DOI":"10.1016\/j.diabres.2020.108628","article-title":"Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - significance of pregnancy planning and prepregnancy HbA1c","volume":"172","author":"\u017burawska-Kli\u015b","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2024022320511181800_B23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00125-014-3163-6","article-title":"Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes","volume":"57","author":"Kallas-Koeman","year":"2014","journal-title":"Diabetologia"},{"key":"2024022320511181800_B24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00125-022-05864-6","article-title":"Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study","volume":"66","author":"Thorius","year":"2023","journal-title":"Diabetologia"},{"key":"2024022320511181800_B25","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2337\/dc21-0472","article-title":"Risk of major congenital malformations or perinatal or neonatal death with insulin detemir versus other basal insulins in pregnant women with preexisting diabetes: the real-world EVOLVE study","volume":"44","author":"Mathiesen","year":"2021","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12884-016-1177-4","article-title":"Design and rationale of a large, international, prospective cohort study to evaluate the occurrence of malformations and perinatal\/neonatal death using insulin detemir in pregnant women with diabetes in comparison with other long-acting insulins","volume":"17","author":"Mathiesen","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"2024022320511181800_B27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project","volume":"384","author":"Villar","year":"2014","journal-title":"Lancet"},{"key":"2024022320511181800_B28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/EDE.0b013e318225c2be","article-title":"DAGitty: a graphical tool for analyzing causal diagrams","volume":"22","author":"Textor","year":"2011","journal-title":"Epidemiology"},{"key":"2024022320511181800_B29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/pds.1471","article-title":"Guidelines for good pharmacoepidemiology practices (GPP)","volume":"17","author":"International Society for Pharmaceutical Engineering","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024022320511181800_B30","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.2337\/dc23-S015","article-title":"15. Management of diabetes in pregnancy: Standards of Care in Diabetes\u20142023","volume":"46","author":"American Diabetes Association","year":"2023","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B31","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2337\/dc19-1908","article-title":"Dietary patterns of insulin pump and multiple daily injection users during type 1 diabetes pregnancy","volume":"43","author":"Neoh","year":"2020","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/14767058.2013.806896","article-title":"Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester","volume":"27","author":"Damm","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2024022320511181800_B33","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc19-2527","article-title":"Continuous glucose monitoring in pregnancy: importance of analyzing temporal profiles to understand clinical outcomes","volume":"43","author":"Scott","year":"2020","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B34","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00125-012-2455-y","article-title":"Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study","volume":"55","author":"Bell","year":"2012","journal-title":"Diabetologia"},{"key":"2024022320511181800_B35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00125-022-05820-4","article-title":"Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?","volume":"66","author":"Desoye","year":"2023","journal-title":"Diabetologia"},{"key":"2024022320511181800_B36","doi-asserted-by":"crossref","first-page":"e000601","DOI":"10.1136\/bmjopen-2011-000601","article-title":"Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study","volume":"2","author":"Persson","year":"2012","journal-title":"BMJ Open"},{"key":"2024022320511181800_B37","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00125-017-4314-3","article-title":"Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study","volume":"60","author":"Murphy","year":"2017","journal-title":"Diabetologia"},{"key":"2024022320511181800_B38","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2337\/dc13-1031","article-title":"Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome","volume":"36","author":"Damm","year":"2013","journal-title":"Diabetes Care"},{"key":"2024022320511181800_B39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00404-007-0541-z","article-title":"Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors","volume":"278","author":"Melamed","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"2024022320511181800_B40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/47\/3\/384\/748591\/dc231281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/47\/3\/384\/748591\/dc231281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T20:51:48Z","timestamp":1708721508000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/47\/3\/384\/154040\/Fetal-Overgrowth-and-Preterm-Delivery-in-Women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12,21]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc23-1281","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}